Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01336855 · ClinicalTrials.gov registry record
Collection of Blood for Multiple Collaborative Studies
A clinical trial of HIV, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01336855: Recruiting study of HIV, sponsored by University of California, San Francisco.
NCT01336855 is a study of HIV that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,000 participants, above the 433-participant average among 303 other HIV trials with a reported enrollment target (362% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01336855, a study of HIV, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.
Primary Outcome
Viral load
Conditions Studied
Study Locations (1)
California
- San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 1988-01 |
| Est. Completion | 2030-01 |
What NCT01336855 shows while recruiting
NCT01336855 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 433-participant average among 303 other HIV trials with a reported enrollment target (362% higher).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 0 interventions.
NCT01336855 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01336855 about?
NCT01336855 is a clinical study titled "Collection of Blood for Multiple Collaborative Studies". This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.
What is the current status of trial NCT01336855?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 1988-01. Estimated completion is 2030-01.
What conditions does trial NCT01336855 study?
This clinical trial studies the following conditions: HIV.
Who is sponsoring clinical trial NCT01336855?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01336855 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01336855's enrollment target sits among peer trials
2,000 10th of 303 higher than 294 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia